These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Pramipexole: new indication. Restless legs: still no satisfactory drug treatment. Prescrire Int; 2007 Feb; 16(87):12. PubMed ID: 17323517 [TBL] [Abstract][Full Text] [Related]
10. Adverse effects of ropinirole-treated restless leg syndrome (RLS) during smoking cessation. Juergens TM J Clin Sleep Med; 2008 Aug; 4(4):371-2. PubMed ID: 18763430 [TBL] [Abstract][Full Text] [Related]
11. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial. Montplaisir J; Karrasch J; Haan J; Volc D Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755 [TBL] [Abstract][Full Text] [Related]
12. A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome. Garcia-Borreguero D; Grunstein R; Sridhar G; Dreykluft T; Montagna P; Dom R; Lainey E; Moorat A; Roberts J Sleep Med; 2007 Nov; 8(7-8):742-52. PubMed ID: 17512789 [TBL] [Abstract][Full Text] [Related]
13. An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease. Stoner SC; Dahmen MM; Makos M; Lea JW; Carver LJ; Rasu RS Ann Pharmacother; 2009 Sep; 43(9):1426-32. PubMed ID: 19690226 [TBL] [Abstract][Full Text] [Related]
15. Critical review of ropinirole and pramipexole - putative dopamine D(3)-receptor selective agonists - for the treatment of RLS. Varga LI; Ako-Agugua N; Colasante J; Hertweck L; Houser T; Smith J; Watty AA; Nagar S; Raffa RB J Clin Pharm Ther; 2009 Oct; 34(5):493-505. PubMed ID: 19744006 [TBL] [Abstract][Full Text] [Related]
16. Restless legs syndrome caused by quetiapine successfully treated with ropinirole in 2 patients with bipolar disorder. Urbano MR; Ware JC J Clin Psychopharmacol; 2008 Dec; 28(6):704-5. PubMed ID: 19011442 [No Abstract] [Full Text] [Related]
17. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome. Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947 [TBL] [Abstract][Full Text] [Related]
18. Punding in patients on dopamine agonists for restless leg syndrome. Evans AH; Stegeman JR Mov Disord; 2009 Jan; 24(1):140-1. PubMed ID: 18855926 [No Abstract] [Full Text] [Related]
19. Ropinirole in a child with attention-deficit hyperactivity disorder and restless legs syndrome. Konofal E; Arnulf I; Lecendreux M; Mouren MC Pediatr Neurol; 2005 May; 32(5):350-1. PubMed ID: 15866437 [TBL] [Abstract][Full Text] [Related]
20. Pramipexole (Mirapex) for restless legs syndrome. Med Lett Drugs Ther; 2007 Mar; 49(1257):26-8. PubMed ID: 17375031 [No Abstract] [Full Text] [Related] [Next] [New Search]